Research No Longer Recruiting Patients
The research studies listed below are no longer recruiting patients.
If you have questions about any of the research studies listed below, please leave a voicemail for our research team at 206-320-2200.
A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sclerosis
Sponsor: Roche Gententech
Type of MS: RR
Contact: Yuriko Courtney 206-320-2647
DioGenix Specificity Study
Differential Gene Expression Profiling in the Blood of Patients with Multiple Sclerosis and MS Mimics
Types of MS: RR, SP
DioGenix Steroid Study
DifferTemporal Gene Expression and microRNA Profiling in the Blood of Patients with Demyelinating Disease Treated with Steroids ential Gene Expression Profiling in the Blood of Patients with Multiple Sclerosis and MS Mimics
Types of MS: RR, CIS
An extension protocol for multiple sclerosis patients who participated in Genzyme-sponsored studies of alemtuzumab.
Type of MS : RR
Tygris: Tysabri global observational program in safety
A dose-blind, multicenter, extension study to determine the long-term safety and efficacy of two doses of BG00012 monotherapy in subjects with relapsing-remitting multiple sclerosis
A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) + Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis
A dose blinded extension study to the CBAF312A2201 study to evaluate long-term safety, tolerability and efficacy of BAF312 given orally once daily in patients with relapsing-remitting multiple sclerosis
Type of MS : RR
JCV antibody program in patients with relapsing multiple sclerosis receiving or considering treatment with Tysabri: Stratify-2
Types of MS : RR
Multiple Sclerosis Center1600 East Jefferson
Seattle, WA 98122
Enlarge Text on this page
Scroll down to “enlarge text” on the bottom of the page, then click on the size you would like.